Abstract: Embodiments of the disclosure relate to a method of assembling a glass article. The glass article includes a display module and a glass sheet. In the method, an electronic ribbon connector is positioned in a vertical position. The electronic ribbon connector has a first end connected to the display module and a second free end. The display module is attached to the glass sheet. Adhesive is applied to the glass sheet around the display module. A frame is arranged over the glass sheet. The frame has a depending edge and a slot positioned adjacent to the depending edge. The frame is moved towards the glass sheet such that the second free end of the electronic ribbon connector extends through the slot and such that the depending edge of the frame contacts the adhesive.

Abstract: A glass container for storing pharmaceutical formulations may include a glass body formed from a Type IA or Type IB glass composition according to ASTM Standard E438-92(2011). The glass body may include a wall portion with an inner surface and an outer surface, a heel portion and a floor portion, wherein the inner surface of the glass container is formed by the inner surface of the glass body. The glass body may include at least a class A2 base resistance or better according to ISO 695, at least a type HGB2 hydrolytic resistance or better according to ISO 719 and Type 1 chemical durability according to USP <660>. The glass container does not comprise a boron-rich layer on the inner surface of the glass body in as formed condition.

Abstract: A coated glass pharmaceutical package includes a glass body having a Type 1 chemical durability according to USP 660, at least a class A2 base resistance or better according to ISO 695, and at least a type HGB2 hydrolytic resistance or better according to ISO 719, the glass body having an interior surface and an exterior surface and a wall extending therebetween. A lubricous coating having a thickness of less than or equal to 90 nm may be positioned on at least a portion of the exterior surface of the glass body but not on any portion of the interior surface. The portion of the coated glass package with the lubricous coating comprises a coefficient of friction that is at least 20% less than an uncoated glass package and the coefficient of friction does not increase by more than 30% after undergoing a depyrogenation cycle including exposure to a temperature of 250° C. for a time period of 30 minutes.

Abstract: According to embodiments, a coated pharmaceutical container may include a pharmaceutical container comprising an interior surface and an exterior surface, wherein the pharmaceutical container may include a glass composition that has Class HGA1 hydrolytic resistance when tested according to the ISO 720 testing standard. The coated pharmaceutical container may further include a coating bonded to at least a portion of the exterior surface but not on any portion of the interior surface. The coating may have a coefficient of friction less than or equal to 0.7, and the coated pharmaceutical container may be thermally stable after heating at a temperature of at least 260° C. for a time period of 30 minutes.

Abstract: A glass container including a body having a delamination factor less than or equal to 10 and at least one marking is described. The body has an inner surface, an outer surface, and a wall thickness extending between the outer surface and the inner surface. The marking is located within the wall thickness. In particular, the marking is a portion of the body having a refractive index that differs from a refractive index of an unmarked portion of the body. Methods of forming the marking within the body are also described.

Abstract: Disclosed is a glass article. The glass article includes a cold-formed glass sheet having a first major surface and a second major surface. The second major surface is opposite to the first major surface. The first major surface has a curvature with a variable radius of curvature including a minimum radius of curvature at a vertex of the curvature. The curvature extends in a first direction from the vertex and in a second direction from the vertex. The first direction is opposite to the second direction. The variable radius of curvature continuously increases with increasing distance from the vertex in the first direction and in the second direction.

Abstract: According to embodiments, a method of making a coated pharmaceutical container, may include: forming a glass tube; forming the glass tube into a pharmaceutical container comprising an interior surface and an exterior surface; and applying a coating to the exterior surface. The coating has a coefficient of friction less than or equal to 0.7 relative to a second pharmaceutical container when tested in a vial-on-vial testing jig under a normal load of 30 N. The coated pharmaceutical container may be thermally stable after depyrogenation at a temperature of at least 260° C. for 30 minutes in air.

Abstract: Embodiments of a method of cold-forming a glass article are disclosed. In one or more embodiments, the method includes bending a glass sheet over the chuck such that a first major surface of the glass sheets conforms to a bending surface of the chuck. In one or more embodiments, the method includes adhering a frame to the second major surface of the glass sheet such that at least one spacer is positioned between the glass sheet and the frame.

Abstract: The disclosure relates to fame constructions comprising a glass substrate and a curved surface defining at least one curvature, wherein the engagement of the glass substrate with the curved surface imparts a curvature on the glass substrate.

Abstract: A glass container including a body having a delamination factor less than or equal to 10 and at least one marking is described. The body has an inner surface, an outer surface, and a wall thickness extending between the outer surface and the inner surface. The marking is located within the wall thickness. In particular, the marking is a portion of the body having a refractive index that differs from a refractive index of an unmarked portion of the body. Methods of forming the marking within the body are also described.

Abstract: Coated pharmaceutical packages are disclosed. The coated pharmaceutical packages may Include a glass body formed from borosilicate glass that meets Type 1 criteria according to USP <660> or alkali aluminosilicate glass having a Class HGA 1 hydrolytic resistance when tested according to the ISO 720-1985 testing standard. A low-friction coating comprising a polymer may be positioned on a portion of the exterior surface. A coefficient of friction of an abraded area of the portion of the exterior surface with the low-friction coating may be less than 0.7 after exposure to a temperature of 260° C. for 30 minutes and abrasion under a load of at least 10 N and does not have observable damage. A retained strength of the coated glass article in horizontal compression does not decrease by more than 20% after the temperature exposure and the abrasion.

Abstract: A glass container comprises a glass body comprising a first region under a compressive stress extending from a surface of the glass body to a depth of compression and a second region extending from the depth of compression into a thickness of the glass body, the second region being under a tensile stress. The glass container also includes a localized compressive stress region having a localized compressive stress extending from the surface to a localized depth of compression within the body. The localized depth of compression is greater than the depth of compression of the first region. The glass container also includes a crack re-direction region extending in a predetermined propagation direction, wherein the crack re-direction region possesses a higher tensile stress than the tensile stress in the second region in a sub-region of the crack re-direction region, the sub-region extending substantially perpendicular to the predetermined propagation direction.

Abstract: The disclosure relates to fame constructions comprising a glass substrate and a curved surface defining at least one curvature, wherein the engagement of the glass substrate with the curved surface imparts a curvature on the glass substrate.

Abstract: A method for finishing a glass or ceramic article includes applying a force to the glass or ceramic article. The force is applied to the glass or ceramic article at least when the glass or ceramic article is at a temperature that is greater than or equal to a creep temperature of the glass or ceramic article. Holding the force to the glass or ceramic article as the glass or ceramic article is cooled to a temperature that is less than the creep temperature of the glass or ceramic article.

Abstract: Coated pharmaceutical packages may comprise a glass body formed from a borosilicate glass composition having a Type 1 chemical durability according to USP 660, the glass body having an interior surface and an exterior surface and a wall extending therebetween. A low-friction thermally stable coating having a thickness of ?1 ?m may be positioned on at least a portion of the exterior surface. The low-friction coating may comprise a silane. The portion of the exterior surface of the coated pharmaceutical package may have a coefficient of friction that is at least 20% less than an uncoated pharmaceutical package formed from the same borosilicate glass composition.

Abstract: An ion exchange tank is provided. The ion exchange tank includes a processing chamber and an additive chamber separated by a weir system, the weir system having a flow channel fluidly connecting the processing chamber to the additive chamber, wherein the flow is divided from the additive chamber by a first partition and divided from the processing chamber by a second partition, wherein the additive chamber comprises a solids-absorbing material disposed therein.

Abstract: A glass article including a frame having a frame support surface, a glass sheet having a first major surface and a second major surface in which the second major surface is opposite to the first major surface, and an adhesive bead disposed between the frame support surface and the second major surface. The adhesive bead defines a bead path. The adhesive bead has a cross-section perpendicular to the bead path, and the cross-section includes a width and a height. The height is a maximum dimension perpendicular to the second major surface of the glass sheet, and the width is a maximum dimension parallel to the second major surface of the glass sheet. An aspect ratio of the height to the width is at least 0.6, and the width is 2 mm or less.

Abstract: Embodiments of this disclosure include a cold-formed cover glass substrate comprising a first end, a second end opposing the first end, opposing first and second major surfaces, a width, a length; a first axis and a second axis both extending along the width or both extending along the length; a first portion extending from the first axis to the first end that comprises a first radius of curvature, and a second portion extending from the first axis to the second axis. In one or more embodiments, the second portion includes a second radius of curvature that increases or decreases from the first axis to the second axis. In one or more embodiments, the cold-formed cover glass substrate comprises a third portion extending from the second axis to the second end, wherein the third portion differs from the first portion.

Abstract: A glass container including a body having a delamination factor less than or equal to 10 and at least one marking is described. The body has an inner surface, an outer surface, and a wall thickness extending between the outer surface and the inner surface. The marking is located within the wall thickness. In particular, the marking is a portion of the body having a refractive index that differs from a refractive index of an unmarked portion of the body. Methods of forming the marking within the body are also described.

Abstract: An ion exchange tank is provided. The ion exchange tank includes a processing chamber and an additive chamber separated by a weir system, the weir system having a flow channel fluidly connecting the processing chamber to the additive chamber, wherein the flow is divided from the additive chamber by a first partition and divided from the processing chamber by a second partition, wherein the additive chamber comprises a solids-absorbing material disposed therein.